期刊文献+

氯吡格雷联合低分子肝素、拜阿司匹林治疗动静脉内瘘血栓形成的临床疗效 被引量:2

暂未订购
导出
摘要 目的观察氯吡格雷联合低分子肝素和拜阿司匹林治疗动静脉内瘘血栓形成的临床疗效。方法选取维持性血液透析(MHD)动静脉内瘘血栓形成患者24例,分为观察组和对照组,观察组患者发现内瘘堵塞后采用氯吡格雷首剂300 mg口服,然后75 mg,1次/d,加拜阿司匹林0.3 g,1次/d,口服,连用3 d后,改为0.1 g,1次/d,加低分子肝素钙5 000 U,皮下注射,2次/d,连用7 d。对照组采用尿激酶50万U溶于100 mL生理盐水通过外周静脉滴注,30 min滴完。连续3 d如内瘘不能再通者接受手术取栓治疗或重新造瘘。结果观察组内瘘再通率高于对照组(χ2=4.16,P<0.05)。两组溶栓治疗前后患者血压、血BUN、Scr、凝血酶原时间(PT)及血浆纤维蛋白原(Fib)等临床指标比较,差异无统计学意义(T=158,P=0.648)。结论氯吡格雷对MHD患者动静脉内瘘血栓形成进行溶栓治疗,其操作简单,创伤小,费用少,有较高的临床应用价值。
作者 墨玺霞
出处 《内科》 2011年第6期569-571,共3页 Internal Medicine
  • 相关文献

参考文献4

  • 1樊晓智,李月红,刘宇,肖顺贞,韦洮,于仲元.自体动静脉内瘘阻塞原因分析及护理对策[J].中国血液净化,2004,3(6):319-321. 被引量:82
  • 2Herbent JM,Frebel D, Valleek,et al. Clopidogvel,a novel antiplatelet and antithrombotic agent [ J ]. Cardio vascular Drug Reviews, 1993, 11(2) :180 -198.
  • 3Ischinger TA. Antithrombotics in intervention cardiology: optimixing treatment and strategies [ J ]. Am J Cardiol, 1998,82 ( 5 B ) : 25 L - 28L.
  • 4刘萍,徐建民.氯吡格雷的抗栓作用[J].中国新药与临床杂志,2001,20(5):384-386. 被引量:25

二级参考文献21

  • 1李月红,于仲元,王玉柱,朱军,田松.188例尿毒症病人内瘘成熟影响因素分析[J].中国血液净化,2002,1(2):11-14. 被引量:31
  • 2汤兵.血液透析血管通路的选择和并发症的诊治[J].肾脏病与透析肾移植杂志,1995,4(5):470-472. 被引量:30
  • 3[1]Feliste R, Delebassee D, Simon MF, et al. Broad spectrum anti-platelet activity of ticlopidine and PCR 4099 involves the suppression of the effects of released ADP[J]. Thromb Res, 1987, 48:403-415.
  • 4[2]Minno GD, Cerbone AM,Mattioli PL,Turco S,Iovine C, Mancini M. Fun ctionally thrombasthenic state in normal platelets following the administration of ticlopidine[J]. J Clin Invest, 1985, 75:328-330.
  • 5[3]Gachet C,Savi P,Ohlmann P,Maffrand JP,Jakobs KH, Cazenave JP. AD P receptor induced activation of guanine nucleotide binding proteins in rat plat elet membranes--an effect selectively blocked by the thienopyridine clopidogre l[J]. Throb Haemost, 1992, 68:79-83.
  • 6[4]Maffrand JP, Bernat A, Delebassee D, Defreyn G, Cazenave JP, Gordon JL. ADP plays a key role in thrombogenesis in rats[J]. Thromb haemost, 1988, 5 9:225-230.
  • 7[5]Born GVR. Adenosine diphosphate as a mediator of platelet aggregatio n in vivo: an editorial view[J]. Circulation, 1985, 72:741-746.
  • 8[6]Zawilska KM, Born GVR, Begent NA. Effect of ADP-utilizing enzymes o n the arterial bleeding time in rats and rabbits[J]. Br J Haematol, 1988, 50:3 17-319.
  • 9[7]Herbert JM, Bemat A, Mur A, Maffrand JP. Effect of aprotinin on ble ed ing occurring after administration of clopidogrel in the rat[J]. Thromb Res, 1 993, 65:S160.
  • 10[8]Shand RA, Smith JR, Wallis RB. Expression of the paltelet procoagul a nt activity in vivo in thrombus formation in an extracorporeal shunt in the rat[J]. Thromb Res, 1984, 36:223-232.

共引文献105

同被引文献39

引证文献2

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部